Results 201 to 210 of about 916,473 (292)
Re-designing materials for biomedical applications: from biomimicry to nature-inspired chemical engineering. [PDF]
Perera AS, Coppens MO.
europepmc +1 more source
CHEMICAL ENGINEERING DIVISION SUMMARY REPORT FOR APRIL, MAY, AND JUNE 1955
openalex +2 more sources
Chemical Engineering in the Imperial College of Science, London [PDF]
A. R. Ubbelohde
openalex +1 more source
TGF‐β has a complex role in cancer, exhibiting both tumor‐suppressive and tumor‐promoting properties. Using a series of differentiated tumoroids, derived from different stages and mutational background of colorectal cancer patients, we replicate this duality of TGF‐β in vitro. Notably, the atypical but highly aggressive KRASQ22K mutation rendered early‐
Theresia Mair+17 more
wiley +1 more source
CHEMICAL ENGINEERING DIVISION SUMMARY REPORT FOR JULY, AUGUST, SEPTEMBER 1958
openalex +2 more sources
Loss of the frequently mutated chromatin remodeler ARID1A, a subunit of the SWI/SNF cBAF complex, results in less open chromatin, alternative splicing, and the failure to stop cells from progressing through the cell cycle after DNA damage in bladder (cancer) cells. Created in BioRender. Epigenetic regulators, such as the SWI/SNF complex, with important
Rebecca M. Schlösser+11 more
wiley +1 more source
Tracing insights into human metabolism using chemical engineering approaches. [PDF]
Cordes T, Metallo CM.
europepmc +1 more source
Chronic TGF‐β exposure drives epithelial HCC cells from a senescent state to a TGF‐β resistant mesenchymal phenotype. This transition is characterized by the loss of Smad3‐mediated signaling, escape from senescence, enhanced invasiveness and metastatic potential, and upregulation of key resistance modulators such as MARK1 and GRM8, ultimately promoting
Minenur Kalyoncu+11 more
wiley +1 more source